Canadian Journal of Infectious Diseases and Medical Microbiology · 2005 · 174 citations · 25 references
MedicineImmunologyInfectious DiseasesHepatologyImmunizationVirologyAntiviral TherapyLiver DiseaseLiver Function TestsViral DiagnosticsViral HepatitisViral Hepatitis TreatmentHepatitis SerologyHepatitis Virus DiagnosisHepatitis Virus TestingSerological ScreeningTherapeutic Hepatitis B VaccinesVaccine AvailabilityViral Load AssaysViral Load Assessment
Hepatitis B virus (HBV) chronically infects approximately 250,000 Canadians and 350 million people worldwide. Without intervention, approximately 15% to 40% of chronically infected individuals will eventually develop cirrhosis, end-stage liver disease or hepatocellular carcinoma, or require liver transplantation. The availability and extensive use of the HBV vaccine has dramatically reduced the number of incident infections in Canada and worldwide. Effective therapeutic agents have been and continue to be developed to treat chronic infection. The present review provides a comprehensive overview of diagnostic tests for HBV infection and immunity, and elaborates on HBV risk factors, vaccine prevention and therapeutic monitoring. HBV diagnosis is accomplished by testing for a series of serological markers of HBV and by additional testing to exclude alternative etiological agents such as hepatitis A and C viruses. Serological tests are used to distinguish acute, self-limited infections from chronic HBV infections and to monitor vaccine-induced immunity. Nucleic acid testing for HBV-DNA is increasingly being used to quantify HBV viral load and measure the effectiveness of therapeutic agents. Given the multitude of available tests and the complexity of clinical management, there is a critical need for greater coordination among clinicians, diagnostic laboratory personnel and researchers to define optimal laboratory diagnostic and monitoring assays so that the appropriate tests are used to maximize prevention and optimize treatment outcomes.
25
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
Hwai‐I Yang, Sheng‐Nan Lu, Yun‐Fan Liaw et al. · New England Journal of Medicine · 2002 · 1.2K citations
A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness
Lieven Stuyver, Sija De Gendt, Caroline Van Geyt et al. · Microbiology · 2000 · 914 citations
Treatment of Acute Hepatitis C with Interferon Alfa-2b
Elmar Jaeckel, Markus Cornberg, Heiner Wedemeyer et al. · New England Journal of Medicine · 2001 · 802 citations · Full text